Tenthwave raises $4M seed extension after outperforming MRI-guided FUS in cadaver study
Summary
Pittsburgh-based Tenthwave secured a $4M seed extension from UPMC Enterprises and Innovation Works after publishing cadaver study results showing their ultrasound-guided FUS system achieved equivalent thalamic ablation zone accuracy to MRI-guided systems at 8x lower cost per procedure. The extension funds first-in-human safety study preparation.
Why it matters
Equivalent accuracy to MRI-guided FUS in a cadaver study is the key technical validation Tenthwave needed to attract clinical partners for first-in-human work. At 8x lower procedure cost, their system could make focused ultrasound tremor treatment available at outpatient neurology clinics globally rather than only academic FUS centers.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial